Q1 2025 Zomedica Corp Earnings Call Transcript

May 15, 2025 / 08:30 PM GMT

Release Date Price: $0.059 (+1.64%)

Transcript 8-K10-Q

Key Points

Positve

Zomedica Corp (ZOMDF) achieved its 17th consecutive quarter of year-over-year record revenue, with Q1 2025 revenue reaching $6.5 million, a 4% increase from the previous year.
The company saw a 32% year-over-year growth in international revenue, driven by expansion into key international markets.
Zomedica Corp (ZOMDF) launched five new assays in 2024, contributing to a 41% year-over-year growth in the TrueForma platform during Q1 2025.
The company has made strategic investments in infrastructure, such as expanding manufacturing and distribution facilities, which are expected to improve efficiency and reduce costs.
Zomedica Corp (ZOMDF) reduced its cash operating expenses by $1.2 million year-over-year and $1 million sequentially, demonstrating a focus on cost management.

Negative

The company reported a net loss of $63.8 million for Q1 2025, primarily due to a $55.8 million non-cash impairment expense.
Diagnostic segment revenues decreased by 25%, with challenges in the Vet Guardian product line impacting overall performance.
Sales and marketing expenses increased by 22% compared to the prior quarter, raising concerns about high marketing costs relative to industry averages.
Zomedica Corp (ZOMDF) faces challenges in gaining institutional coverage and investment banking relations due to its stock price being below $1 and trading on the OTC market.
The company has no immediate plans for a reverse stock split or stock buyback, which may affect investor sentiment regarding stock price appreciation.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ZOMDF.PK - Zomedica Corp
Q1 2025 Zomedica Corp Earnings Call
May 15, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, ladies and gentlemen, and welcome to the Zumetica first quarter 2025 earnings call.

At this time, all lines are in the listen-only mode.

Following the presentation, we will conduct a question and answer session.

If at any time during this call you require immediate assistance, please press 0 for the operator.

This call is being recorded on Thursday, May 15, 2025.

I would now like to turn the conference over to Jason Westfall, senior director of BNA. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.